Celerion Increases Screening Pass Rate by 28% with Grove AI
Celerion
Philip Bach
Executive Vice President, Global Clinical Research

Grove's AI-accelerated PRM enables clinical research organizations to recruit and engage with participants at scale. At Grove, they’re committed to building purposeful, people-centric, and safe innovations to serve their communities. They’re deeply grateful to their investors, partners, and clinical research leaders—from site coordinators to patient advocates to clinical operations executives—for supporting their mission to advance clinical trials.
Showing 3 Grove AI Customer Success Stories
Celerion
Philip Bach
Executive Vice President, Global Clinical Research
K2 Medical Research
Sean Stanton
Co-Founder
Leading Site Network
No matching case studies